H.C.
The post H.C. Wainwright Reaffirms Their Buy Rating on vTv Therapeutics (VTVT) appeared first on Smarter Analyst.
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on vTv Therapeutics (VTVT) today and set a price target of $6.00. The companys shares closed last Wednesday at $2....
https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-vtv-therapeutics-vtvt/#SmarterAnalyst
You must login before you can post a comment.